キット・タンパク質・ベクターなど 製品詳細情報

Code No. CY-8058V2
CircuLex S100A12/EN-RAGE ELISA Kit Ver.2
価格(税別) ¥107,800
包装 96 Assay
在庫 10以上
（2024/04/19 17:00時点）
キット構成品 Microplate, 10X Wash Buffer, Dilution Buffer, Human S100A12 Standard, HRP conjugated Detection Antibody, Substrate Reagent, Stop Solution
使用目的 This Kit is used for the quantitative measurement of human S100A12/EN-RAGE in serum, plasma, and other biological media.
保存温度 4°C
メーカー MBL
サンプル Serum, Plasma
測定範囲 20 - 1,280 pg/mL
感度 8.2 pg/mL～
別称 CAGC, CGRP, MRP-6, CAAF1
製品カテゴリー 分野:免疫 代謝
データ

使用文献
  1. Kikkawa T et al. Significance of measuring S100A12 and sRAGE in the serum of sepsis patients with postoperative acute lung injury. Dig Surg. 27, 307-312 (2010)(PMID:20689292)
  1. Smith DJ et al. Reduced soluble receptor for advanced glycation end products in chronic obstructive pulmonary disease. Eur Respir J. 37, 516-22 (2011)(PMID:20595148)
  1. Nakashima A et al. Effect of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and the Proinflammatory RAGE Ligand (EN-RAGE, S100A12) on Mortality in Hemodialysis Patients. Clin J Am Soc Nephrol. 5, 2213-9 (2010)(PMID:20847094)
  1. Andrés Cerezo L et al.Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with new-onset rheumatoid arthritis. Arthritis Res Ther. 13, R122 (2011)(PMID:21791097)
  1. Takahashi G et al.Retrospective study on the effect of tight glucose control in postoperative sepsis patients using an artificial pancreas. J Infect Chemother.17, 812-20 (2011)(PMID:21681499)
  1. Kim JK et al. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis. Atherosclerosis 220, 208-14 (2012)(PMID:21906738)
  1. Han EC et al. Expression of Pro-inflammatory Protein S100A12 (EN-RAGE) in Beh_et's Disease and Its Association with Disease Activity: A Pilot Study. Ann Dermatol. 23, 313-20 (2011)(PMID:21909201)
  1. Takahashi G et al. Changes in Serum S100A12 and sRAGE Associated with Improvement of the PaO(2)/FiO(2) Ratio following PMX-DHP Therapy for Postoperative Septic Shock. Eur Surg Res. 47, 135-140 (2011)(PMID:21921634)
  1. Liu K et al. Transcriptome signature in young children with acute otitis media due to Streptococcus pneumoniae. Microbes Infect. 14, 600-9 (2012)(PMID:22306269)
  1. Yamamoto T et al. Changes in circulating biomarkers during a single hemodialysis session. Hemodial Int. 17, 59-66 (2013)(PMID:22716238)
  1. Silajd?i? E et al. A critical evaluation of inflammatory markers in Huntington's Disease plasma. J Huntingtons Dis. 2, 125-34 (2013)(PMID:25063434)
  1. Peiskerová M et al. Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease--a prospective observational study. BMC Nephrol. 14, 142 (2013)(PMID:23844967)
  1. Tydén H et al. Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus. Rheumatology Rheumatology 52, 2048-55 (2013)(PMID:23942785)
  1. Kim HS et al. Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels. Nephrology 18, :777-82 (2013)(PMID:24124651)
  1. Zakiyanov O et al. Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study. BMC Nephrol. 14, 245 (2013)(PMID:24188108)
  1. Rothmund F et al. Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritis. Arthritis Care Res. 66, 949-55 (2014)(PMID:24339418)
  1. Hara M et al. S100A12 gene expression is increased in peripheral leukocytes in chronic kidney disease stage 4-5 patients with cardiovascular disease. Nephron Clin Pract. 123, 202-8 (2013)(PMID:23921255)
  1. Sundqvist M et al. Increased intracellular oxygen radical production in neutrophils during febrile episodes of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome. Arthritis Rheum. 65, 2971-83 (2013)(PMID:23983059)
  1. Glasnovic A et al. Decreased level of sRAGE in the cerebrospinal fluid of multiple sclerosis patients at clinical onset. Neuroimmunomodulation. 21, 226-33 (2014)(PMID:24603633)
  1. Farkas G Jr et al. Analysis of plasma levels and polymorphisms of S100A8/9 and S100A12 in patients with acute pancreatitis. Pancreas. 43, 485-7 (2014)(PMID:24622086)
  1. Kim JK, Park S, Lee MJ, Song YR, Han SH, Kim SG, Kang SW, Choi KH, Kim HJ, Yoo TH.; Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis. Atherosclerosis. 220:208-14. 2012(PMID:21906738)
  1. Han EC, Cho SB, Ahn KJ, Oh SH, Kim J, Kim DS, Lee KH, Bang D.; Expression of Pro-inflammatory Protein S100A12 (EN-RAGE) in Beh_et's Disease and Its Association with Disease Activity: A Pilot Study. Ann Dermatol. 23: 313-20. 2011(PMID:21909201)
  1. Takahashi G, Hoshikawa K, Matsumoto N, Shozushima T, Onodera C, Kan S, Akitomi S, Kikkawa T, Tomisawa Y, Kojika M, Sato N, Inoue Y, Suzuki K, Wakabayashi G, Endo S.; Changes in Serum S100A12 and sRAGE Associated with Improvement of the PaO(2)/FiO(2) Ratio following PMX-DHP Therapy for Postoperative Septic Shock. Eur Surg Res. 47(3):135-140. 2011(PMID:21921634)
  1. Liu K, Chen L, Kaur R, Pichichero M.; Transcriptome signature in young children with acute otitis media due to Streptococcus pneumoniae. Microbes Infect. 14: 600-9. 2012(PMID:22306269)
  1. Saito T et al. Distinct expression patterns of alveolar "alarmins" in subtypes of chronic lung allograft dysfunction. Am J Transplant. 14, 1425-32 (2014)(PMID:24787265)
  1. Fukasawa H et al. Plasma levels of the pro-inflammatory protein S100A12 (EN-RAGE) are associated with muscle and fat mass in hemodialysis patients: a cross-sectional study. Nutr J. 13, 48 (2014)(PMID:24884769)
  1. Opatrna S et al. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products. Ther Apher Dial. 18, 309-16 (2014)(PMID:24965297)
  1. Isoyama N et al. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients. Nephrol Dial Transplant. 30, 84-91 (2014)(PMID:25074436)
  1. Bae CB et al. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease. J Rheumatol. 41, 2403-8 (2014)(PMID:25274901)
  1. Ma D et al. S100A12 expression in patients with primary biliary cirrhosis. Immunol Invest. 44, 13-22 (2014)(PMID:25313445)
  1. He YY et al. Usefulness of S100A12 as a prognostic biomarker for adverse events in patients with heart failure. Clin Biochem. 48, 329-33 (2015)(PMID:25438075)
  1. Turnier JL et al. Urine S100 proteins as potential biomarkers of lupus nephritis activity. Arthritis Res Ther. 19, 242
    (2017)(PMID:29065913)
  1. Šumová B et al. Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study. Rheumatol Int. 39, 469-478 (2019)(PMID:30392117)
  1. Yamasaki Y et al. S100A12 and vascular endothelial growth factor can differentiate Blau syndrome and familial Mediterranean fever from systemic juvenile idiopathic arthritis. Clin Rheumatol. 38, 835-840 (2019)(PMID:30406853)
  1. Nikolakopoulou Z et al. Plasma S100A8/A9 heterodimer is an early prognostic marker of acute kidney injury associated with cardiac surgery. Biomark Med. 13, 205-218 (2019)(PMID:30810341)
  1. Choi S et al. Comparison of pressure- and volume-controlled ventilation during laparoscopic colectomy in patients with colorectal cancer. Sci Rep. 9, 17007 (2019)(PMID:31740727)
  1. Kumar NP et al. Systemic RAGE Ligands Are Upregulated in Tuberculosis Individuals With Diabetes Co-Morbidity and Modulated by Anti-Tuberculosis Treatment and Metformin Therapy. BMC Infect Dis. 19, 1039 (2019)(PMID:31818258)
  1. Li SC et al. Serum proteins may facilitate the identification of Kawasaki disease and promote in vitro neutrophil infiltration. Sci Rep. 10, 15645 (2020)(PMID:32973234)

※在庫につきましては2024年04月19日 17時00分時点における在庫数を表示してあります。
※価格の赤色表示につきましては、キャンペーン価格の表示となっております。
※このサイトからは直接注文はできません。ご注意ください。
※保存温度の表記について： RT: 室温
※本サイトの掲載製品は、品質改良のため予告なく仕様などの変更、または販売中止となる場合がございます。あらかじめご了承ください。

MBLCopyright (C)2015 Medical ＆ Biological Laboratories Co., Ltd. All Rights Reserve